Type 1 protein tyrosine kinases in benign and malignant breast lesions
- 1 December 1998
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 33 (6) , 514-521
- https://doi.org/10.1046/j.1365-2559.1998.00498.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary resultsBreast Cancer Research and Treatment, 1996
- The Prognostic Value of Epidermal Growth Factor Receptor (EGFR) in Breast Cancer Patients: Results of a follow-up study on 149 patientsActa Oncologica, 1994
- Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroupBritish Journal of Cancer, 1991
- Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failureThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancerBritish Journal of Cancer, 1988
- Growth Factor Receptor Tyrosine KinasesAnnual Review of Biochemistry, 1988
- A thousand and one protein kinasesCell, 1987
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984
- Mapping of the human gene for epidermal growth factor receptor (EGFR) on the p13→q22 region of chromosome 7Cytogenetic and Genome Research, 1983
- Epidermal growth factor stimulates phosphorylation in membrane preparations in vitroNature, 1978